# data[].attributes.body
Chlamydia is a common sexually transmitted disease caused by a bacterial infection called Chlamydia trachomatis. Chlamydia can be spread through oral, vaginal, or anal sex if engaging with a partner who has the disease. Additionally, chlamydia can be spread to infants during childbirth.

Symptoms of chlamydia in women include abnormal vaginal discharge, a burning sensation while urinating, or painful vaginal sex. Though some may have no symptoms of chlamydia, despite being infected (Medline, 2024).

Anybody can get chlamydia, and it can be cured by antibiotics, but if left untreated it can cause serious health problems.

# data[].attributes.body
1. Decrease the rate of chlamydia diagnoses in Black Teens and young adult women in 2-3 years.

2. Decrease the rate of chlamydia related diseases and complications among Black Teens and Young Adult women in 2.5 years.

# data[].attributes.body
SF Young Adult STI Prevention Program

# data[].attributes.headline
San Francisco County Ranks High in Chlamydia Reported Cases

# data[].attributes.subject
San Francisco County Ranks High in Chlamydia Reported Cases

# data[].attributes.body
In 2020, 14 counties surpassed the state's chlamydia rate (445.6 cases/100,000). San Francisco had one of the highest rate at 638.2. (California Department of Public Health, 2020).

# data[].attributes.headline
Chlamydia Shown to Affect Women More Than Men

# data[].attributes.subject
Chlamydia Shown to Affect Women More Than Men

# data[].attributes.body
Chlamydia, a sexually transmitted bacterial infection, results in worse health outcomes for women than in men. Research shows that if left untreated, women may develop Infertility, Pelvic Inflammatory Disease, or Ectopic Pregnancy (Centers for Disease Control, 2022). Based on 2020 statistics, Black and young adult women in California reported Chlamydia at 2.5 to 4.5 times higher compared to other population Chlamydia average rates (STD Surveillance Executive Summary, 2020).

# data[].attributes.attachment_link.description
Chlamydia Fact Sheet from CDC. What is chlamydia? How common is chlamydia? How do people get chlamydia? And more…

# data[].attributes.headline
"Doxy-PEP: A Promising STI Prevention, But for Whom?"

# data[].attributes.subject
"Doxy-PEP: A Promising STI Prevention, But for Whom?"

# data[].attributes.body
Exciting news: This article highlights the effectiveness of a treatment called doxy-PEP for preventing sexually transmitted infections (STIs) in cisgender men and transgender women. While this approach has shown promise in reducing STI rates, it hasn't proven as effective for cisgender women. Further research is needed to understand why and to ensure that all individuals, regardless of gender identity, have access to effective STI prevention methods. Since STI rates are disproportionately high among Black communities, this setback could exacerbate existing health disparities, especially for young Cis-gender Black women.

(Stone, 2023)

# data[].attributes.attachment_link.readable_text
There's a treatment that works like a morning-after pill for sexually transmitted infections - an antibiotic taken in the hours after unprotected sex. And it can significantly lower the chance of developing common STIs like chlamydia and syphilis.

In fact, the approach has proven effective enough that federal guidelines are now being finalized so that more doctors and public health departments can offer it to those who're at high risk of STIs.

Except so far, "doxy-PEP" - short for doxycycline post-exposure prophylaxis (PEP) - is only recommended for men who have sex with men and transgender women.

"There's enthusiasm for doxy-PEP and you're seeing a lot of places rolling it out, but not for cisgender women," says Dr. Jenell Stewart, an infectious disease specialist at Hennepin Healthcare and the University of Minnesota.

And for the time being, it's likely to stay that way, given the results of a study published on Wednesday in the New England Journal of Medicine. It represents the first clinical trial to test whether doxy-PEP can be effective in this population.

"Unfortunately, it didn't work in our study - we didn't see any reduction of new STIs," says Stewart, one of the study's authors.

The results seem to cast doubt on hopes that doxy-PEP can work in a broader population and help solve the troubling rise in STI rates. Research shows women are more likely to have certain STIs and to suffer from serious complications.

But the topline results are not necessarily the final word.

"I think it's premature to discard this intervention," says Dr. Jeanne Marrazzo, who directs the National Institute of Allergy and Infectious Diseases and was not involved in the study. "There is biological plausibility, and such an urgent need to control these infections in women."

So why exactly did doxy-PEP fall short?

The year-long study followed nearly 450 women in Kenya who were mostly in their 20s and already taking HIV PrEP, an indication that they're at heightened risk of STIs.

The trial design was similar to a previous study that found doxy-PEP was effective at reducing bacterial STIs among men who have sex with men.

Recent data suggest that despite biological differences between cisgender men and cisgender women, doxycycline should still be protective against bacterial STIs.

The levels of doxycycline in rectal and vaginal fluids are similar and high enough to inhibit infections from chlamydia and syphilis, says Dr. Connie Celum, professor of global health and medicine at the University of Washington in Seattle

"I don't think there's a reason to suspect it wouldn't work," she says, " I really do think adherence appears to be the major factor in this study."

This is what Dr. Stewart also suspects based on hair samples collected from a subset of the participants.

Even though a majority of the women said they were taking doxycycline regularly after sex, their analysis shows the numbers were, in reality, much lower. Only about a third of the samples had doxycycline present.

The discrepancy isn't necessarily all that surprising to Marrazzo, who wrote an editorial that accompanied the study.

She points out that people are often eager to tell their doctor they're following instructions and taking care of their health.

"It's similar in clinical trials, right? Participants want to stay in the studies," she says.

Stewart says they're gathering more data to understand why many women ended up not taking doxycycline, and she plans to launch a new trial in the U.S.

"While this is disappointing and we have a delay in giving this potential intervention to cisgender women, it also gives me optimism," says Stewart. "We just didn't have enough participants taking the medicine to see an impact, so I think the question is still on the table."

Awareness of STI risk may be lower in Kenya and that could partially explain the lack of adherence in the study. STI testing is not widely available and most infections are asymptomatic. That's in contrast to Western countries where testing is a regular part of HIV PrEP programs.

"Men who have sex with men and trans women in the U.S. and Europe are much more aware of STIs than women in Africa for whom testing is not available," says Celum, "They may not have perceived themselves to need this."

Other factors could be at play, too. There's less antibiotic resistance in gonorrhea in the U.S. compared to Kenya. The women in the trial were also having fewer sexual partners than those enrolled in the previous trials and therefore they were taking the medication less often.

Marrazzo says future clinical trials need to take into account why adherence was low so that researchers and doctors can get a clear picture of whether doxy-PEP is a viable option for women.

This situation reminds her of when guidance on oral HIV PrEP was first rolled out, which was based largely on data from men who have sex with men and transgender women.

"This is like deja vu," she says, noting that there just isn't good enough data on doxy-PEP's effect in women. "What is so disheartening about these results and the current state of the CDC guidelines is that, once again, women are not going to be included with definitive data."

# data[].attributes.attachment_link.title
There's an effective morning-after pill for STIs but it's not clear it works in women

# data[].attributes.attachment_link.description
Doxy-PEP can be taken a few hours after sex and is effective at preventing sexually transmitted infections. New research finds it's less effective for women but that may not be the final word.

# data[].attributes.attachment_caption
Black Female Youth Chlamydia Rates in SF 

# data[].attributes.headline
Chlamydia Rates in SF Disproportionately Affects Black Women

# data[].attributes.subject
Chlamydia Rates in SF Disproportionately Affects Black Women

# data[].attributes.body
In 2022, Black/African American Female Youth aged 15-19 years old in San Francisco were diagnosed with Chlamydia 10x more compared to White Female Youth of the same age. Black/African American Female Youth aged 20-24 years old are diagnosed 7x more than White Female Youth of the same age (Pipkin et al., 2023)

# data[].attributes.headline
Lack of STI Testing among College Aged Students  

# data[].attributes.subject
Lack of STI Testing among College Aged Students  

# data[].attributes.body
70 percent of college students were sexually active in 2018, yet only 8% of 20% of college men, and 20% of college women were tested for STI's (Jennings, 2020). A lack of STI testing for women can lead to serious Chlamydia outcomes such as infertility and Pelvic Inflammatory Disease (PID) (SF City Clinic, 2014).

# data[].attributes.attachment_link.readable_text
Many sexually active college students have never been tested for sexually transmitted infections (STIs). A novel study published in the Journal of American College Health suggests that STI self-testing kits could change that.

According to the US Centers for Disease Control, combined cases of syphilis, gonorrhea, and chlamydia among young adults aged 15-24 years reached an all-time high in the US in 2018. Yet, while approximately 70% of college students were sexually active in the past year, only 8% of college men and 20% of college women were tested for STIs, wrote study authors.

In the first study of its kind, researchers from George Mason University's College of Health and Human Services conducted an online survey of >400 students aged ≥18 years from a large mid-Atlantic university to assess their HIV/STI testing behaviors, comfort with self-collection procedures, and intention to use self-collection services for STI testing if offered on campus.

Older students (aged ≥25 years), those who lived off campus, and those who identified as lesbian, gay, bisexual, or an identity other than heterosexual were found to be significantly more likely to have ever been tested for HIV and other STIs vs younger students (aged 18-24 years), those who lived on campus, and those who identified as heterosexual.

Most students (88%) said they were "likely" or "extremely likely" to use STI self-testing services if they could take it home and test themselves in the privacy of their home or residence, while more than half (59%) said they would use STI self-testing services if they could test themselves in a private room on campus.

The study also found that students are more comfortable with some aspects of STI self-collection testing procedures if they are virtual. Students said they would be "very comfortable" completing an online request form for an STI self-collection kit (70.8%), answering questions about their sexual behaviors in an online questionnaire (75.2%), and getting text messages about their STI test results (54.1%).

Meanwhile, approximately 50% of students said they would be "very comfortable" discussing their STI test results with a health care provider.

"We hope to be able to offer STI self-testing options on campus in the near future and encourage other universities to consider the same, as we found that most students, regardless of age, sexual experience, and previous testing experience, were interested in self-testing," said lead author Lisa Lindley, DrPH, MPH, associate professor of Global and Community Health, College of Health and Human Services, George Mason University, in a university press release. "These findings are especially timely during the COVID-19 pandemic, as access to HIV/STI testing in traditional settings has become more challenging and the CDC is recommending at-home HIV tests."

# data[].attributes.attachment_link.title
Study: Most College Students Don't Get STI Testing, but Self-tests May Help

# data[].attributes.attachment_link.description
Over 80% of college students surveyed said they were "likely" or "extremely likely" to use STI self-testing services if they could take it in the privacy of their own home.

# data[].attributes.body
Communication between partners can determine whether a condom is worn during sex. "When communication was good, they were more likely to make informed decisions about condom use. When they judged that this conversation would be distressing, they chose not to voice their preference, usually resulting in unprotected sex" (Alldred, Najiha, 2021).

If there is discomfort when discussing practicing safe sex, parties are less likely to use a condom. This poses a risk to higher Chlamydia rates among women as transmission of STIs becomes more likely without condom use.

# data[].attributes.headline
Family Stigma Can Lead to Lower Rates of Safe Sex Practices Among Young Black Women

# data[].attributes.subject
Family Stigma Can Lead to Lower Rates of Safe Sex Practices Among Young Black Women

# data[].attributes.body
A study conducted among Undergraduate African American students found that "Exposure to parental abstinence messages predicted less sexual experience but also less consistent use of protection", as well as, "exposure to parental messages that highlighted sex as relational predicted greater sexual assertiveness and more comfort with one’s sexual experience level" (Leath et al., 2020). This poses a risk to young black women contracting Chlamydia as they are less likely to use protection during sex if exposed to abstinence messages from parents.

# data[].attributes.headline
Systemic Racism and Structural Oppression Lead to Lack of Access

# data[].attributes.subject
Systemic Racism and Structural Oppression Lead to Lack of Access

# data[].attributes.body
Historically, U.S. policies and societal structures have perpetuated social, economic, and educational marginalization of Black individuals, most especially black women. The results of this treatment is shown in the prevalent lower income and educational achievement for this population, often resulting in a lack of access to health care and preventive measures (Cohn, Harrison, 2022). This causes a direct risk to worsening disease outcomes of black women who contract Chlamydia due to not having access to health care and preventative measures.

# data[].attributes.body
The cost of testing and treatment can be a barrier to accessing care, particularly for those without adequate healthcare coverage or financial resources. Increasing awareness, improving access to affordable testing and treatment, and addressing systemic healthcare disparities are crucial steps in combating the burden of chlamydia on young Black women's health.

Testing for chlamydia can vary in cost depending on the type of test needed and whether one has health insurance, ranging from $0 to $250(Planned Parenthood, n.d.). However, access to affordable testing and treatment can be limited, especially for young Black women. Programs like EPSDT and CHIP are meant to provide preventative services, but many states do not adequately promote or evaluate these programs, leaving them inaccessible to those who need them most.

(Loosier et al., 2014)

# data[].attributes.attachment_link.readable_text
Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

San Francisco Health Center offers the following services related to the testing and treatment of sexually transmitted diseases and infections (STD/STIs). Contact the health center by booking an appointment or calling for more information.

The cost of STD/STI testing and treatment will vary based on what tests you need, your income, and whether or not you use health insurance. Total final price may vary between $0-250.

Most health centers accept health insurance. If you don't have insurance, speak with a staff member to discuss your payment options. Total final price may vary between $0-250.

Ready to schedule your appointment?

It's important to get tested as soon as possible if you've had unprotected sexual contact, you find out your partner has an STD/STI, or if you think you've been exposed to anything.

Not sure what to expect? Read more to better understand how STD/STI testing works at Planned Parenthood.

We can test for gonorrhea and chlamydia. If this test shows an infection, then we will provide you with treatment and explain how your partner can be treated.

For testing involving urine samples, including chlamydia and gonorrhea, do not urinate or engage in sexual intercourse for one hour before testing.

Many STD/STI tests require a genital exam.

Counseling and confidential (private) testing for STD/STIs are provided by trained staff who are sensitive to your needs and concerns.

Some STD/STI testing and treatment services may be covered by your insurance. If you want to use your insurance, please be sure to have your insurance information at the time of your visit.

Payment is expected at time of service unless other arrangements have been made.

There may be additional charges for lab and blood work.

You can privately and easily book your appointment online for select services 24/7. For the full set of services, you can call 415-821-1282 to book your appointment. Health center staff can also answer any questions you may have.

Book Online

Ask us anything. Seriously.

Between our trained sexual health educators or chat bot, we can answer your questions about your sexual health whenever you have them. And they are free and confidential.

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking "Allow All Cookies" you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.

We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.

We use qualitative data, including session replay, to learn about your user experience and improve our products and services.

We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.

# data[].attributes.attachment_link.title
STD Testing in San Francisco, CA - Herpes, Chlamydia, Gonorrhea Tests

# data[].attributes.attachment_link.description
STD Testing for herpes, chlamydia, gonorrhea, genital warts, syphilis, etc. at the San Francisco Health Center. Trusted health care for nearly 100 years by Planned Parenthood.

# data[].attributes.headline
What happens if Chlamydia is left untreated?

# data[].attributes.subject
What happens if Chlamydia is left untreated?

# data[].attributes.body
Pelvic Inflammatory Disease (PID) and Ectopic Pregnancy (EP)are complications often associated with Chlamydia. When PID IS diagnosed early, it can be treated but left undiagnosed, it leads to further complications like Ectopic pregnancy, Infertility and in some cases, lifelong pelvic and abdominal pain. Numerous studies has showed a clear association between EP,PID and prior Chlamydia infections, that Chlamydia significantly increases the risk of EP occurrence.

(Xia et al., 2020)

(Price et al., 2016)

(den Heijer et al., 2019)

# data[].attributes.attachment_link.readable_text
What is PID?

Pelvic inflammatory disease is an infection of a woman's reproductive organs. It is a complication often caused by some STDs, like chlamydia and gonorrhea. Other infections that are not sexually transmitted can also cause PID.

How do I get PID?

You are more likely to get PID if you

Have an STD and do not get treated;

Have more than one sex partner;

Have a sex partner who has sex partners other than you;

Have had PID before;

Are sexually active and are age 25 or younger;

Douche;

Use an intrauterine device (IUD) for birth control. However, the small increased risk is mostly limited to the first three weeks after the IUD is placed inside the uterus by a doctor.

How can I reduce my risk of getting PID?

The only way to avoid STDs is to not have vaginal, anal, or oral sex.

If you are sexually active, you can do the following things to lower your chances of getting PID:

Being in a long-term mutually monogamous relationship with a partner who has been tested and has negative STD test results;

Using latex condoms the right way every time you have sex.

How do I know if I have PID?

There are no tests for PID. A diagnosis is usually based on a combination of your medical history, physical exam, and other test results. You may not realize you have PID because your symptoms may be mild, or you may not experience any symptoms. However, if you do have symptoms, you may notice

Pain in your lower abdomen;

Fever;

An unusual discharge with a bad odor from your vagina;

Pain and/or bleeding when you have sex;

Burning sensation when you urinate; or

Bleeding between periods.

You should

Be examined by your doctor if you notice any of these symptoms;

Promptly see a doctor if you think you or your sex partner(s) have or were exposed to an STD;

Promptly see a doctor if you have any genital symptoms such as an unusual sore, a smelly discharge, burning when peeing, or bleeding between periods;

Get a test for chlamydia and gonorrhea every year if you are sexually active and younger than 25 years of age.

Have an honest and open talk with your health care provider if you are sexually active and ask whether you should be tested for other STDs.

Can PID be cured?

Yes, if PID is diagnosed early, it can be treated. However, treatment won't undo any damage that has already happened to your reproductive system. The longer you wait to get treated, the more likely it is that you will have complications from PID. While taking antibiotics, your symptoms may go away before the infection is cured. Even if symptoms go away, you should finish taking all of your medicine. Be sure to tell your recent sex partner(s), so they can get tested and treated for STDs, too. It is also very important that you and your partner both finish your treatment before having any kind of sex so that you don't re-infect each other.

You can get PID again if you get infected with an STD again. Also, if you have had PID before, you have a higher chance of getting it again.

What happens if I don't get treated?

If diagnosed and treated early, the complications of PID can be prevented. Some of the complications of PID are

Formation of scar tissue both outside and inside the fallopian tubes that can lead to tubal blockage;

Ectopic pregnancy (pregnancy outside the womb);

Infertility (inability to get pregnant);

Long-term pelvic/abdominal pain.

Sources

American College of Obstetricians and Gynecologists (ACOG). Pelvic Inflammatory Disease. ACOG Patient Education Pamphlet, 1999.

Westrom L and Eschenbach D. In: K. Holmes, P. Sparling, P. Mardh et al (eds). Sexually Transmitted Diseases, 3rd Edition. New York: McGraw-Hill, 1999, 783-809.

You can add this content to your website by syndicating.

# data[].attributes.attachment_link.description
Pelvic inflammatory disease is an infection of a woman's reproductive organs. It is a complication often caused by some STDs, like chlamydia and gonorrhea. Other infections that are not sexually transmitted can also cause PID.

# data[].attributes.body
CDPH. California Department of Public Health. (2020). https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/2020-STD-Surveillance-Executive-Summary.pdf

Centers for Disease Control and Prevention. (2022, April 12). https://www.cdc.gov/std/chlamydia/stdfact-chlamydia.htm#:~:text=Chlamydia%20is%20a%20common%20STD,that%20occurs%20outside%20the%20womb

“Chlamydia Infections | Chlamydia | Chlamydia Symptoms.” MedlinePlus, U.S. National Library of Medicine, 19 Mar. 2024, medlineplus.gov/chlamydiainfections.html.

Pipkin, S., Nguyen, T., Underwood, N., & Cohen , S. (2023, December 5). HIV/STI Update. San Francisco Department of Public Health. https://www.sf.gov/sites/default/files/2023-12/HC_HIVSTI%20update_2023.cleaned_0.pdf

Stone, W. (2023, December 20). https://www.npr.org/sections/health-shots/2023/12/20/1220691158/doxy-pep-sti-prevention-pill-women-after-sex

Alam, Najiha, and Pam Alldred. (16 Apr. 2021) https://doi.org/10.3390/ijerph18084257.

Leath, Seanna et al. (27 August, 2020) https://journals.sagepub.com/doi/10.1177/0361684320948539

Cohn, Tanya, and Carmen V. Harrison. “A systematic review exploring racial disparities, social determinants of health, and sexually transmitted infections in black women.” Nursing for Women’s Health, vol. 26, no. 2, Apr. 2022, pp. 128–142, https://doi.org/10.1016/j.nwh.2022.01.006.

Jennings, Sydney. (15 Oct. 2020) www.patientcareonline.com/view/study-most-college-students-don-t-get-sti-testing-but-self-tests-may-help.

Parenthood, P. (n.d.). STD testing in San Francisco, CA - herpes, chlamydia, gonorrhea tests. Planned Parenthood. https://www.plannedparenthood.org/health-center/california/san-francisco/94109/san-francisco-health-center-3997-90200/std-testing-treatment

(Loosier et al., 2014) Children’s Health Insurance Program (CHIP) programs are not guaranteed to cover EPSDT services

https://pubmed.ncbi.nlm.nih.gov/25118966/

(Xia et al., 2020)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946389/

Price et al.

https://www.ncbi.nlm.nih.gov/books/NBK350645/

# data[].attributes.body
Black teens and young adult women aged 15-25 in San Francisco

All teens and young adults in SF

# data[].attributes.body
1. Increase in the number of black teens and young adults   in San Francisco who use contraceptive barriers in 9 months.

2. Increase access to STI testing for black teen and young adult women in San Francisco in 12 months.

3. Increase in the number of black teens, young adults and their partner(s) who are confident and/or able to communicate with their partners about their sexual history & practicing safe sex within 9 months.

# data[].attributes.body
1. Increase in the number of black teens and young adult women in SF who know how chlamydia is spread, prevented, treated, and its effects on the body among black teen and young adult women by 6 months.

2. Increase in the number of black teen and young adult women in SF who believe that they are susceptible to chlamydia without safe sex practices in 3 months.

3. Increase in the number of black teen and young adult women in SF who believe that getting tested for STIs can reduce the risk of contracting chlamydia in 5 months.

4. Increase in the number of black teens and young adult women in San Francisco who believe it is important to share their sexual history and talk about safe sex with their partner to reduce the risk of contracting chlamydia in 5 months.

# data[].attributes.headline
Building on cultural wealth of Black teen and young adults

# data[].attributes.subject
Building on cultural wealth of Black teen and young adults

# data[].attributes.body
With our population focusing on black teens and young adult women within San Francisco being the most affected by rates of chlamydia, it is important for us to utilize their existing skills in modern technology and the internet. This program will include a social media campaign component to build on the cultural wealth that our population of teens and young adults ages 15-25 years old have on their knowledge and skills with using social media and internet searches.

# data[].attributes.headline
Program Activities Phase 2: Program Implementation (mos. 4-21)

# data[].attributes.subject
Program Activities Phase 2: Program Implementation (mos. 4-21)

# data[].attributes.body
Conduct Social Media Campaign

create social media accounts (Instagram, TikTok, Twitter)

50 Instagram posts every two weeks

20 TikTok videos 1-2 every month

150 Twitter posts once a week for 2 years

create informational posts for socials (how chlamydia is spread, how it’s treated, how it affects the body, current chlamydia rates in the US, prevention, how and where to be tested, and conversation starters for how to talk to partners about STIs)

Bye Bye STI Young Adult Workshop

High Schools: 1 Staff and 3 Student Interns will conduct 7 workshop sessions (90 minutes each) per high school in 10 total SF High Schools in 1 academic year. In the Fall Semester, there will be 3 sessions. In the Spring Semester, there will be 4 sessions. Each session shall have 50 participants each.

College: 2 Staff will conduct 2 sessions (90 minutes each) in 1 academic year with up to 50 participants per session

Topics:

What is Chlamydia

What Chlamydia Does to the Human Body

Who is vulnerable to Chlamydia

Current Chlamydia Prevalence Rate in 15-25 year olds

How Chlamydia is Spread

Chlamydia Prevention Efforts

How to Talk to Your Partner about STIs (Conversation Starters)

How and Where to get STI Testing + What our Program Can Do For You + Our Social Media Pages

Approaches:

Slideshow Presentation

"How Infectious Diseases Spread" Interactive Game

Kahoot Game at the end of the presentation with prizes

Condom & Dental Dams Distribution

Contraceptives and Preventative Care referrals

Partner with local clinics to get referrals for testing and follow-ups.

Partnership with planned parenthood for STI testing and follow-ups.

Partnerships with private healthcare professionals to provide STI testing as well as one-on-one follow-ups.

Acquire condoms and contraceptives.

Distribute condoms and contraceptives to participants.

# data[].attributes.headline
Program Activities Phase 1: Program Development (mos.1-3)

# data[].attributes.subject
Program Activities Phase 1: Program Development (mos.1-3)

# data[].attributes.body
Hire staff (mostly BIPOC identifying)

Recruit 3 student interns (mostly BIPOC identifying)

Find brick and mortar location to serve as headquarters in where program planning will be conducted

Reach out to high schools in SF who are willing to have us hold workshops in their classrooms

Reach out to healthcare professionals who are willing to partner with our program to provide low-cost or free testing and follow-up care

Develop a curriculum for training student interns

Develop curriculum for chlamydia and safe sex workshops

# data[].attributes.body
1. Kahoot game at the end of the workshop, to review materials and reward with food

2. Evaluation in the form of a survey given to each school and college campus participant to assess knowledge retention.

# data[].attributes.headline
SF Young Adult STI Prevention Program Budget

# data[].attributes.subject
SF Young Adult STI Prevention Program Budget

# data[].attributes.attachment_link.title
Budget Template Chlamydia .docx - Google Docs

# data[].attributes.body
1 curriculum for educational place-based workshops

1 training curriculum for student interns to teach workshops

7 workshops in 10 high schools 3,600 total participants

4 workshops in 2 colleges 300 total participants

4 paid staff

3 student interns

distribute 2000 condoms & 500 dental dams

50 Instagram posts, 20 TikTok videos, 150 Twitter posts

45 posters displayed throughout the high school and college campuses we are visiting

# data[].attributes.headline
SF Young Adult STI Prevention Program Staffing

# data[].attributes.subject
SF Young Adult STI Prevention Program Staffing

# data[].attributes.body
Project Director (Full Time)

Project Coordinator (Part Time)

2 Health Educators (Part Time)

3 Student Interns (less than Part Time)